Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 44 min ago
PreprintCC BYmedRxiv

Increasing risks of recurrence following community-associated Clostridioides difficile infection in Oxfordshire 2000-2025

  1. 1University of Oxford

Abstract

BackgroundClostridioides difficile infections (CDI) continue to cause substantial morbidity and mortality, with increasing incidence in some countries post-COVID-19. Recurrence affects 10-20% of CDI patients: whether risk factors have changed over time is unclear, particularly post-COVID-19.

MethodsUsing electronic health records from hospitals in Oxfordshire, UK, including results from community samples, we estimated the incidence of CDI recurrence across different calendar periods between 2000-2025. To investigate whether risk factors had changed over time, we used interaction tests within multivariable Fine-Gray regression models (modelling death as a competing risk), using backwards elimination, starting from 39 risk factors identified from the literature.

ResultsRecurrence occurred within 1-year in 12.6%, 12.5%, 10.8% and 13.1% of CDI cases in "high virulence" 2003-2008 (n=527), "post-high virulence" 2008-2012 (n=252), "pre-pandemic" 2012-2020 (n=143) and "post-pandemic" 2020-2025 (n=110) periods respectively. The only factor with evidence of variation in its association with recurrence over time was surveillance classification (heterogeneity p=0.019; others p>0.05). Compared with hospital-onset cases, community-onset community-associated cases had increasing recurrence risks over time (subdistribution hazard ratios (SHRs)=2.05 (95% CI 1.27-3.31) in "post-pandemic" and 1.86 (1.16-2.98) in "pre-pandemic"), especially compared to the "high virulence" era of the early 2000s (SHR=0.81 (0.56-1.16)). This heterogeneity persisted after adjusting for baseline blood tests as a marker of severity (heterogeneity p=0.022).

ConclusionsCompared with hospital-onset hospital-associated cases, recurrence risks increased for community-onset community-associated CDI cases over time. Recurrence is a key contributor to overall CDI incidence and the underlying causes of increasing risks with community-onset community-associated cases should be explored further.

Short summaryOver 2000-2025, risk of recurrence following Clostridioides difficile infection increased significantly for community-onset community-associated cases, compared to hospital-onset hospital-associated cases. Older age, hospital exposure, immunosuppression, chronic kidney disease, diverticular disease, enteral feeding and recent sepsis/bacteraemia were significantly associated with recurrence.

Related

  1. Factors Associated With Recurrence in Patients With Benign Paroxysmal Positional Vertigo Following Canal Repositioning Therapy.
    Navdeep Kaur, Rachna Dhingra, Sumit Prinja
    CureusPeer-reviewedCC BYFull textNeurologyEurope PMCPMC
  2. The Trajectory of Gastrointestinal Symptom Experience Following Fecal Microbiota Transplant for Recurrent Clostridioides Difficile Infection
    Hijab Zehra, Nataliia Kuchma, Annie W. Lin +9
    Journal of clinical gastroenterologyPeer-reviewedCC BY-NC-ND 4.0Full textInfectious diseasePMC
  3. Case Report: Immune-related colitis complicated by Clostridioides difficile-associated colitis
    Wenjuan Chen, Wanqian Zhang, Chaoqun Sun +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  4. Evaluating long-term recurrence of cholesteatoma following primary surgery: an umbrella review of surgical techniques and patient factors
    Edi Handoko, Rizki Ekaputra Handoko, Ahmad Dian Wahyudi
    The Journal of Laryngology and OtologyPeer-reviewedCC BY 4.0Full text2 citedGeneral medicinePMC
  5. A single-cell derived immune risk score predicts recurrence in NSCLC following neoadjuvant chemo-immunotherapy
    Jun Ge, Xuesong Tong, Xingxia Wang +1
    BMC CancerPeer-reviewedCC BYFull textOncologyDOAJ
BibTeX
@misc{dietz2026increasing,
  title = {{Increasing risks of recurrence following community-associated Clostridioides difficile infection in Oxfordshire 2000-2025}},
  author = {E. Dietz and J. Robotham and M. H. Wilcox and C. Brown and R. Hope and B. Muller-Pebody and D. W. Eyre and A. S. Walker},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.30.26364395},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.30.26364395v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Increasing risks of recurrence following community-associated Clostridioides difficile infection in Oxfordshire 2000-2025
AU  - E. Dietz
AU  - J. Robotham
AU  - M. H. Wilcox
AU  - C. Brown
AU  - R. Hope
AU  - B. Muller-Pebody
AU  - D. W. Eyre
AU  - A. S. Walker
PY  - 2026
DA  - 2026/09/30
PB  - medRxiv
DO  - 10.64898/2026.09.30.26364395
UR  - https://www.medrxiv.org/content/10.64898/2026.09.30.26364395v1
AB  - BackgroundClostridioides difficile infections (CDI) continue to cause substantial morbidity and mortality, with increasing incidence in some countries post-COVID-19. Recurrence affects 10-20% of CDI patients: whether risk factors have changed over time is unclear, particularly post-COVID-19.  MethodsUsing electronic health records from hospitals in Oxfordshire, UK, including results from community samples, we estimated the incidence of CDI recurrence across different calendar periods between 2000-2025. To investigate whether risk factors had changed over time, we used interaction tests within multivariable Fine-Gray regression models (modelling death as a competing risk), using backwards elimination, starting from 39 risk factors identified from the literature.  ResultsRecurrence occurred within 1-year in 12.6%, 12.5%, 10.8% and 13.1% of CDI cases in "high virulence" 2003-2008 (n=527), "post-high virulence" 2008-2012 (n=252), "pre-pandemic" 2012-2020 (n=143) and "post-pandemic" 2020-2025 (n=110) periods respectively. The only factor with evidence of variation in its association with recurrence over time was surveillance classification (heterogeneity p=0.019; others p>0.05). Compared with hospital-onset cases, community-onset community-associated cases had increasing recurrence risks over time (subdistribution hazard ratios (SHRs)=2.05 (95% CI 1.27-3.31) in "post-pandemic" and 1.86 (1.16-2.98) in "pre-pandemic"), especially compared to the "high virulence" era of the early 2000s (SHR=0.81 (0.56-1.16)). This heterogeneity persisted after adjusting for baseline blood tests as a marker of severity (heterogeneity p=0.022).  ConclusionsCompared with hospital-onset hospital-associated cases, recurrence risks increased for community-onset community-associated CDI cases over time. Recurrence is a key contributor to overall CDI incidence and the underlying causes of increasing risks with community-onset community-associated cases should be explored further.  Short summaryOver 2000-2025, risk of recurrence following Clostridioides difficile infection increased significantly for community-onset community-associated cases, compared to hospital-onset hospital-associated cases. Older age, hospital exposure, immunosuppression, chronic kidney disease, diverticular disease, enteral feeding and recent sepsis/bacteraemia were significantly associated with recurrence.
ER  -